Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pàgina 1 des de 61 resultats
Methods for diagnosing sepsis
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Pinitol and derivatives thereof for the treatment of metabolic disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SUMMARY OF THE INVENTION
The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for treating conditions associated with insulin resistance. These include disorders such as diabetes mellitus and its chronic complications; obesity; hyperlipidemias and
Pinitol and derivatives thereof for the treatment of metabolic disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SUMMARY OF THE INVENTION
The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for lowering plasma free fatty acids levels and for treating conditions associated with insulin resistance. These conditions associated with insulin resistance can
Compounds and methods for treating insulin resistance and cardiomyopathy
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
All publications mentioned herein are cited for the purpose of familiarizing the reader with the background of the invention. Nothing herein is to be construed as an admission that these references are prior art in relation to the inventions described herein.
Although Type 2 Diabetes
Methods and formulations for treating cardiovascular disease
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods for modulating Lyn kinase activity and treating related disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating lyn kinase activity and treating related disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods for modulating Lyn kinase activity and treating related disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient.
More specifically, the present invention relates to (1) a compound of formula (I)
##STR00002##
HMG1 antibody for treating inflammatory conditions
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: 32681000038SEQ.txt; created 2-22-12, 1.36 KB in size.
TECHNICAL FIELD OF THE
Antagonists of HMG1 for treating inflammatory conditions
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Antagonists of HMG1 for treating inflammatory conditions
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Antagonists of HMG1 for treating inflammatory conditions
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
